Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 19/20 | 0.45 |
| ▸ | KIT | P10721 | 9/20 | 0.45 |
| ▸ | PDGFRA | P16234 | 8/20 | 0.45 |
| ▸ | PDGFRB | P09619 | 7/20 | 0.44 |
| ▸ | MET | P08581 | 3/20 | 0.44 |
| ▸ | KDR | P35968 | 3/20 | 0.44 |
| ▸ | FLT3 | P36888 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31352543 | 0.91 | SMN1; SMN2 (0.50) | CSF1RKITPDGFRAPDGFRBMET | |
| SCHEMBL31352535 | 0.87 | CSF1R (0.45) | CSF1RKITPDGFRAPDGFRBMET | |
| SCHEMBL31352596 | 0.87 | CSF1R (0.46) | CSF1RKITPDGFRAPDGFRBMET | |
| SCHEMBL31352663 | 0.86 | CSF1R (0.45) | CSF1RKITPDGFRAPDGFRBMET | |
| SCHEMBL31352621 | 0.86 | CSF1R (0.43) | CSF1RKITPDGFRAPDGFRBMET | |
| SCHEMBL31352501 | 0.86 | CSF1R (0.48) | CSF1RKITPDGFRAPDGFRBMET | |
| SCHEMBL31352525 | 0.85 | CSF1R (0.53) | CSF1RKITPDGFRAPDGFRBMET | |
| SCHEMBL31352656 | 0.85 | RAB9A (0.49) | CSF1RKITPDGFRAPDGFRBMET | |
| SCHEMBL31352594 | 0.84 | CSF1R (0.44) | CSF1RKITPDGFRAPDGFRBMET | |
| SCHEMBL31352652 | 0.84 | CSF1R (0.51) | CSF1RKITPDGFRAPDGFRBMET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025021943-A1 | QUINAZOLINONE, BENZOXAZINONE AND BENZOXAZEPINONE DERIVATIVES AS PROTEIN KINASE INHIBITORS | NEURALIS (BE) | 2025-01-30 | — | — | WO | disclosed |